Bcl11aem2Sho
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Bcl11aem2Sho |
| Name: |
BCL11 transcription factor A; endonuclease-mediated mutation 2, Stuart Orkin |
| MGI ID: |
MGI:5828771 |
| Synonyms: |
+62DHSdelta |
| Gene: |
Bcl11a Location: Chr11:24028056-24124123 bp, + strand Genetic Position: Chr11, 14.41 cM
|
| Alliance: |
Bcl11aem2Sho page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Hypomorph) |
| Mutation: |
|
Intragenic deletion
|
| |
|
Mutation details: The dominant +62 DNase I Hypersensitive Site in a 10kb enhancer region in intron 2 was targeted for deletion with the CRISPR/Cas9 system. In human, mutations in the orthologous enhancer region are associated with various hemoglobin disorders. The gRNA sequences used were 5'-TCGCTGCCTTCAGTTCTGCT-3' and 5'-CTATTTCCATTGGTGGATAC-3'.
(J:239331, J:260023)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Bcl11a Mutation: |
43 strains or lines available
|
|
| Original: |
J:260023 Canver MC, et al., BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature. 2015 Nov 12;527(7577):192-7 |
| All: |
2 reference(s) |
|